Micro-cap diagnostics company Bionano Genomics prices IPO at $6.125 – Nasdaq

NasdaqBionano Genomics, which sells a proprietary system for next-generation genome analysis, raised $20.6 million by offering 3.36 million units at $6.125, within the revised range of $6 to $7. The company offered 910,000 more units (37%) than anticipated. and more …read more Source:: MicroCap Stock News From Google News

from WordPress https://ift.tt/2vYTGiW
via IFTTT

Newer Post Older Post